as on October 31, 2025 at 11:38 pm IST
Day's Low
Day's High

0.73%
Downside
2.32%
Upside

52 Week's Low
52 Week's High

65.45%
Downside
10.53%
Upside

Check Bridgebio Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$12.7B
EPS (TTM)
-2.898
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-10.2
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
-623.7M
Revenue (TTM)
235.8M
Profit Margin
0.00%
Return On Equity TTM
-1789.67%
Track how Bridgebio Pharma Inc P/E has moved over time to understand its valuation trends.
Bridgebio Pharma Inc in the last 5 years
Lowest (-15.58x)
March 31, 2021
Today (-10.20x)
October 31, 2025
Industry (8.36x)
October 31, 2025
Highest (-2.50x)
June 30, 2022
Today’s Price to Earnings Ratio: -10.20x
Compare market cap, revenue, PE, and other key metrics of Bridgebio Pharma Inc with its industry peers.
| Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | 
|---|---|---|---|---|---|
| BUY | $12.7B | 65.11% | -10.2 | 0.00% | |
| BUY | $41.1B | 489.62% | -16.34 | -259.82% | |
| BUY | $63.1B | 265.59% | -505.15 | -12.96% | |
| BUY | $107.0B | 101.52% | 29.67 | 31.86% | |
| BUY | $68.6B | 20.33% | 15.65 | 32.13% | 
The Bridgebio Pharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bridgebio Pharma Inc investment value today
Current value as on today
₹2,74,159
Returns
₹1,74,159
(+174.16%)
Returns from Bridgebio Pharma Inc Stock
₹1,68,518 (+168.52%)
Dollar Returns*
₹5,642 (+5.64%)
Based on 20 analysts
85.00%
Buy
15.00%
Hold
0.00%
Sell
Based on 20 analysts, 85% of analysts recommend a 'BUY' rating for Bridgebio Pharma Inc. Average target price of $74.28
Get share price movements and forecasts by analysts on Bridgebio Pharma Inc.
What analysts predicted
15.37%UPSIDE
Target Price
$74.28
Current Price
$62.86
Analyzed by
20 Analysts
Target
$74.28
Bridgebio Pharma Inc target price $74.28, a slight upside of 15.37% compared to current price of $62.86. According to 20 analysts rating.
Search interest for Bridgebio Pharma Inc Stock has increased by 46% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:46% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD

Today's Timeline - 03 September
Wed, 04:40 PM
-H.C. Wainwright also maintains Buy rating, increasing price target from $56 to $70, with all analysts rating it Buy.
Wed, 05:11 PM
-J.P. Morgan maintains Buy rating on BridgeBio, raising price target to $70, citing strong pipeline and product launch.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
 POSITIVE IMPACT
POSITIVE IMPACTPrice Rise

In the last 7 days, BBIO stock has moved up by 16.8%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 1 year, Insmed Incorporated has given 188.7% return, outperforming this stock by 18.0%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 3 years, Insmed Incorporated has given 1021.4% return, outperforming this stock by 513.8%
 NEGATIVE IMPACT
NEGATIVE IMPACTRevenue Fall

Revenue is down for the last 3 quarters, 116.63M → 108.11M (in $), with an average decrease of 3.7% per quarter
 NEGATIVE IMPACT
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 3 quarters, -167.42M → -182.74M (in $), with an average decrease of 4.6% per quarter
| Organisation | Bridgebio Pharma Inc | 
| Headquarters | 3160 Porter Drive, Palo Alto, CA, United States, 94304 | 
| Industry | Health Technology | 
| CEO | Dr. Neil Kumar Ph.D. | 
| E-voting on shares | Click here to vote | 
| Name | Title | 
|---|---|
| Dr. Richard H. Scheller Ph.D. | Chairman of Research & Development | 
| Mr. Eli M. Wallace Ph.D. | Chief Scientific Officer of Oncology | 
| Mr. Matthew Outten CPC, MBA | Chief Commercial Officer | 
| Dr. Neil Kumar Ph.D. | Co-Founder, CEO & Director | 
| Dr. Charles J. Homcy M.D. | Co-Founder, Chairman of Pharmaceuticals & Independent Lead Director | 
| Ms. Maricel M. Apuli | Chief Accounting Officer | 
| Dr. Uma Sinha Ph.D. | Chief Scientific Officer | 
| Dr. Eric Michael David J.D., M.D., Ph.D. | Chief Executive Officer of Gene Therapy | 
| Dr. Thomas Trimarchi Ph.D. | CFO & President | 
| Dr. Frank P. McCormick Ph.D. | Co-Founder, Chairman of Oncology & Director | 
Bridgebio Pharma Inc share price today is $62.86 as on . Bridgebio Pharma Inc share today touched a day high of $64.32 and a low of $62.4.
Bridgebio Pharma Inc share touched a 52 week high of $69.48 on and a 52 week low of $21.72 on . Bridgebio Pharma Inc stock price today i.e. is trending at $62.86,which is 9.53% down from its 52 week high and 189.41% up from its 52 week low.
Bridgebio Pharma Inc market capitalisation is $0.01T as on .
Indian investors can start investing in Bridgebio Pharma Inc (BBIO) shares with as little as ₹88.665 or $1 (as of ) using the INDmoney app. 
      
      For example: If you want to invest $10 or ₹886.65 in Bridgebio Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ). 
        Based on Bridgebio Pharma Inc share’s latest price of $62.86 as on October 31, 2025 at 11:38 pm IST, you will get 0.1591 shares of Bridgebio Pharma Inc. Learn more about
          
            fractional shares .
        
Bridgebio Pharma Inc stock has given 65.11% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
        
 Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?